Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more
Emvision Medical Devices Ltd (EMV) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.323x
Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has a cash flow conversion efficiency ratio of -0.323x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.00 Million) by net assets (AU$9.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Emvision Medical Devices Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Emvision Medical Devices Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Emvision Medical Devices Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Emvision Medical Devices Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
1895 of Wisconsin Inc Bancorp
NASDAQ:BCOW
|
0.003x |
|
Cheng Fwa Industrial Ltd
TWO:5426
|
0.026x |
|
Mereo BioPharma Group plc
F:MAH0
|
-0.157x |
|
Northern Ocean Ltd
PINK:NTNOF
|
0.073x |
|
River Valley Community Bancorp
PINK:RVCB
|
N/A |
|
IDREAMSKY TE+H. DL-0001
F:08IA
|
N/A |
|
TAM JAI INTERNATIONAL CO.
F:29S
|
N/A |
|
Marmota Ltd
AU:MEU
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Emvision Medical Devices Ltd (2018–2025)
The table below shows the annual cash flow conversion efficiency of Emvision Medical Devices Ltd from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$9.28 Million | AU$-7.84 Million | -0.844x | -160.85% |
| 2024-06-30 | AU$18.52 Million | AU$-5.99 Million | -0.324x | -298.43% |
| 2023-06-30 | AU$5.12 Million | AU$834.15K | 0.163x | +130.53% |
| 2022-06-30 | AU$7.08 Million | AU$-3.78 Million | -0.534x | -19.47% |
| 2021-06-30 | AU$10.05 Million | AU$-4.49 Million | -0.447x | +24.14% |
| 2020-06-30 | AU$5.52 Million | AU$-3.26 Million | -0.589x | -22.46% |
| 2019-06-30 | AU$4.60 Million | AU$-2.22 Million | -0.481x | +9.42% |
| 2018-06-30 | AU$1.28 Million | AU$-679.59K | -0.531x | -- |